HOFFMANN-LA ROCHE INC. v. APOTEX INC. et al

  1. October 01, 2012

    Roche's Boniva Patent Declared Invalid

    A New Jersey federal judge on Monday invalidated the remaining patent in Hoffmann-La Roche Inc.'s consolidated lawsuits against Apotex Inc., Mylan Inc. and other generic drugmakers over the osteoporosis drug Boniva, issuing an unprompted ruling that the bone treatment is obvious.

  2. March 14, 2012

    Roche Loses Bid To Block Generic Boniva

    Pharmaceutical giant Hoffmann-La Roche Inc. lost a bid Wednesday to block Apotex Inc., Mylan Inc. and other generic-drug makers from releasing a version of the osteoporosis drug Boniva after a judge ruled Roche would have difficulty withstanding challenges to two of the drug's patents.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!